In Response to 'Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?'

Authors

  • Ioannis Gounaris Oncology Centre, Cambridge University Hospitals NHS Trust. Cambridge, United Kingdom
  • Kamarul Zaki Oncology Centre, Cambridge University Hospitals NHS Trust. Cambridge, United Kingdom
  • Pippa Corrie Oncology Centre, Cambridge University Hospitals NHS Trust. Cambridge, United Kingdom

DOI:

https://doi.org/10.6092/1590-8577/3835

Keywords:

Drug Therapy, gemcitabine, Neoplasm Metastasis, Pancreatic Neoplasms

Abstract

No abstract available.

Image: Addenbrooke’s Hospital. Cambridge, United Kingdom.

Downloads

Download data is not yet available.

References

Gounaris I, Zaki K, Corrie P. Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. JOP. J Pancreas (Online) 2010; 11:113-23. [PMID 20208317] (FULLTEXT: http://www.joplink.net/prev/201003/09.html)

Addenbrooke’s Hospital. Cambridge, United Kingdom

Downloads

Published

2010-05-05

How to Cite

Gounaris, I., Zaki, K., & Corrie, P. (2010). In Response to ’Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?’. JOP. Journal of the Pancreas, 11(3), 290. https://doi.org/10.6092/1590-8577/3835

Issue

Vol. 11 No. 3 (2010): May - p. 199-298

Section

REPLY

License

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.